GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Long-Term Debt

JCR Pharmaceuticals Co (TSE:4552) Long-Term Debt : 円13,600 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Long-Term Debt?

JCR Pharmaceuticals Co's Long-Term Debt for the quarter that ended in Dec. 2023 was 円13,600 Mil.

JCR Pharmaceuticals Co's quarterly Long-Term Debt increased from Jun. 2023 (円12,100 Mil) to Sep. 2023 (円13,600 Mil) but then stayed the same from Sep. 2023 (円13,600 Mil) to Dec. 2023 (円13,600 Mil).

JCR Pharmaceuticals Co's annual Long-Term Debt increased from Mar. 2022 (円2,950 Mil) to Mar. 2023 (円5,500 Mil) but then declined from Mar. 2023 (円5,500 Mil) to Mar. 2024 (円0 Mil).


JCR Pharmaceuticals Co Long-Term Debt Historical Data

The historical data trend for JCR Pharmaceuticals Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co Long-Term Debt Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,800.00 5,250.00 2,950.00 5,500.00 -

JCR Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,500.00 12,100.00 13,600.00 13,600.00 -

JCR Pharmaceuticals Co  (TSE:4552) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


JCR Pharmaceuticals Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


JCR Pharmaceuticals Co (TSE:4552) Business Description

Traded in Other Exchanges
Address
3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines